Header Logo

Connection

Idoroenyi Amanam to Disease Progression

Back to Details
This is a "connection" page, showing publications Idoroenyi Amanam has written about Disease Progression.
Idoroenyi Amanam
Connection Strength
0.187
Disease Progression
  1. Use of monoclonal antibody therapy in hematologic patients with mild-to-moderate COVID-19: A retrospective single-center experience. Cancer Med. 2023 05; 12(10):11248-11253.
    View in: PubMed
    Score: 0.187
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.